Affimed Announces Third Quarter 2016 Financial Results and Corporate Update Conference Call

Press Release - October 26, 2016

Download Press Release

Heidelberg, Germany, October 26, 2016 – Affimed N.V. (Nasdaq: AFMD) today announced that on November 2, 2016, the Company will release its financial results for the quarter ended September 30, 2016. The Company’s management team will host a conference call to discuss the Company’s financial results and recent corporate developments on Wednesday, November 2, 2016 at 8:30 a.m. ET. The call can be accessed by dialing one of the numbers listed below five minutes prior to the start of the call and providing the confirmation code 7663835.

Local – Amsterdam, the Netherlands: +31 (0) 20 716 8256
Local – Copenhagen, Denmark: +4532 71 16 59
Local – Frankfurt, Germany: +49 (0) 69 2222 10630
Local – Geneva, Switzerland: +41 (0) 22 417 7109
Local – London, U.K.: +44 (0) 20 3140 8286
Local – New York City, U.S.A.: +1 646 254 3362
Local – Paris, France: +33 (0) 1 76 77 22 22

An audio webcast of the conference call can be accessed in the Webcast section on the Affimed website. A replay of the webcast will be available on Affimed’s website shortly after the conclusion of the call and will be archived on the Affimed website for 30 days following the call.

About Affimed N.V.

Affimed (Nasdaq: AFMD) engineers targeted immunotherapies, seeking to cure patients by harnessing the power of innate and adaptive immunity (NK- and T-cells). We are developing single and combination therapies to treat cancers and other life-threatening diseases. For more information please visit

Affimed IR Contact

Caroline Stewart, Head IR
Phone: +1 347 394 6793
E-Mail: email hidden; JavaScript is required or email hidden; JavaScript is required

Affimed Media Contact

Anca Alexandru, Head of Communications, EU IR
Phone: +49 6221 64793341
E-Mail: email hidden; JavaScript is required

We use cookies to give you the best experience on our website. By continuing to use it, you agree with it.